Ata Naim, Kucukazman Metin, Yavuz Bunyamin, Bulus Hakan, Dal Kursad, Ertugrul Derun Taner, Yalcin Ahmet Arif, Polat Mehmet, Varol Numan, Akin Kadir Okhan, Karabag Aral, Nazligul Yasar
Department of Internal Medicine, Kecioren Teaching and Research Hospital, Ankara, Turkey.
Can J Gastroenterol. 2011 May;25(5):274-6. doi: 10.1155/2011/356761.
Gallstone disease (GD) is a common condition worldwide. Several studies demonstrated that the presence of gallstones is strongly associated with cardiovascular disease. The metabolic syndrome is a highly prevalent cardiovascular condition.
To examine the relationship between complicated GD (CGD) and the metabolic syndrome or its components.
Two hundred seventeen patients with gallstones were examined. All patients underwent biliary ultrasonography after a complete medical history and laboratory examination. Data collection for the diagnosis of metabolic syndrome included measurements of waist circumference, blood pressure and lipids, and biochemical tests.
Of the 217 patients examined, 115 patients (53%) had CGD and 102 patients (47%) had uncomplicated GD (UCGD). There was a significant difference between the number of patients with large gallstones in the CGD and UCGD groups (n=14 [12%] versus n=2 [2%], respectively; P=0.004). Metabolic syndrome, diabetes mellitus and large waist circumference were more prevalent in the CGD group than in the UCGD group. Homeostatic model assessment of insulin resistance scores were higher in the CGD group than in UCGD group (2.51 [95% CI 0.57 to 23.90] versus 2.20 [95% CI 0.09 to 8.87], respectively; P=0.032). Logistic regression analysis revealed that the presence of metabolic syndrome (OR 1.434; 95% CI 1.222 to 1.846, P=0.014), diabetes mellitus (OR 1.493; 95% CI 1.255 to 1.953; P=0.035) and large gallstones (OR 1.153; 95% CI 1.033 to 1.714; P=0.017) were independent predictors of CGD.
Results of the present study demonstrated that metabolic syndrome, diabetes and gallstone size were associated with CGD. Further prospective studies are needed to understand the clinical importance of this association.
胆结石疾病(GD)在全球范围内是一种常见病症。多项研究表明,胆结石的存在与心血管疾病密切相关。代谢综合征是一种高度普遍的心血管病症。
探讨复杂性胆结石疾病(CGD)与代谢综合征及其组分之间的关系。
对217例胆结石患者进行检查。所有患者在完成病史采集和实验室检查后均接受了胆道超声检查。用于诊断代谢综合征的数据收集包括腰围、血压和血脂测量以及生化检测。
在接受检查的217例患者中,115例患者(53%)患有CGD,102例患者(47%)患有非复杂性胆结石疾病(UCGD)。CGD组和UCGD组中大结石患者数量存在显著差异(分别为n = 14 [12%] 与n = 2 [2%];P = 0.004)。代谢综合征、糖尿病和大腰围在CGD组中比在UCGD组中更为普遍。CGD组的胰岛素抵抗稳态模型评估得分高于UCGD组(分别为2.51 [95%可信区间0.57至23.90] 与2.20 [95%可信区间0.09至8.87];P = 0.032)。逻辑回归分析显示,代谢综合征的存在(比值比1.434;95%可信区间1.222至1.846,P = 0.014)、糖尿病(比值比1.493;95%可信区间1.255至1.953;P = 0.035)和大结石(比值比1.153;95%可信区间1.033至1.714;P = 0.017)是CGD的独立预测因素。
本研究结果表明,代谢综合征、糖尿病和结石大小与CGD相关。需要进一步的前瞻性研究来了解这种关联的临床重要性。